Jian Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jian Cui has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Jinxin Shi
Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
3 shared publications- Fei Xiao
Clinical Biobank, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
2 shared publications Gang Zhao
2 shared publications- Gang Zhao
Department of General Surgery, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
2 shared publications - Haizeng Zhang
State Key Laboratory of Molecular Oncology and Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
2 shared publications - Lili Zhang
Clinical Biobank, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
2 shared publications
Latest Publications
- Open Access
- 13 February 2026
- Published by Springer Nature in Human Genomics
- Vol. 20 (1)
Exon skipping as a potential diagnostic biomarker in colorectal cancer: an integrated epigenomic-transcriptomic analysis
Colorectal cancer (CRC) is the third most common cancer globally. Alternative splicing contributes significantly to CRC tumorigenesis through aberrant tran
- 13 February 2026
- Published by Springer Nature in Human Genomics
- Vol. 20 (1)
Open AccessExon skipping as a potential diagnostic biomarker in colorectal cancer: an integrated epigenomic-transcriptomic analysis
Colorectal cancer (CRC) is the third most common cancer globally. Alternative splicing contributes significantly to CRC tumorigenesis through aberrant tran
- Open Access
- 7 February 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Circulating extrachromosomal circular DNA as a prognostic biomarker for colorectal cancer
Background: Delayed detection of recurrence significantly contributes to colorectal cancer (CRC) mortality, underscoring the need for robust prognostic biomarkers. Although extrachromosomal circular DNA (eccDNA) is a known oncogenic driver, its prognostic utility in CRC remains largely unexplored. Methods: In this 6-year prospective cohort study, full-length eccDNA profiling of 153 plasma samples was performed using Nanopore sequencing. Differential eccDNA signatures between recurrence (R, n = 20) and non-recurrence (NR, n = 133) patients enabled construction of predictive models for recurrence and mortality. Functional validation of eccDNAs was conducted in HCT116 cells. Results: Compared to NR patients, R patients exhibited enrichment of eccDNAs derived from chromosome 9, shorter median eccDNA lengths, and reduced variability in eccDNA length. All 4.9–5.0 kb eccDNAs derived from CKM , while other eccDNAs showed a strong genomic distribution correlation between groups (Spearman’s ρ = 0.73). Promoter-derived eccDNAs were enriched in R patients, particularly from the promoter of CARD9 (eccPromoter-CARD9, 10.4-fold increase). Overexpression of eccPromoter-CARD9 significantly promoted CRC cell proliferation and migration. R patients exhibited elevated eccDNAs harboring the hsa-mir-374c cluster in plasma and tissues, and their corresponding miRNAs demonstrated exceptional diagnostic accuracy in CRC-related TCGA cohorts. An eccDNA-based random forest classifier achieved superior recurrence prediction accuracy (AUC > 0.8), correlating with shorter time-to-recurrence (HR = 3.79) and elevated CA125 and CEA levels. Additional eccDNA-based models effectively predicted recurrence-associated mortality (AUC ≥ 0.93). Conclusions: The plasma eccDNA landscape may serve as an early and powerful non-invasive biomarker for CRC prognostication, optimizing risk stratification and guiding personalized treatment.
- 7 February 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Open AccessCirculating extrachromosomal circular DNA as a prognostic biomarker for colorectal cancer
Background: Delayed detection of recurrence significantly contributes to colorectal cancer (CRC) mortality, underscoring the need for robust prognostic biomarkers. Although extrachromosomal circular DNA (eccDNA) is a known oncogenic driver, its prognostic utility in CRC remains largely unexplored. Methods: In this 6-year prospective cohort study, full-length eccDNA profiling of 153 plasma samples was performed using Nanopore sequencing. Differential eccDNA signatures between recurrence (R, n = 20) and non-recurrence (NR, n = 133) patients enabled construction of predictive models for recurrence and mortality. Functional validation of eccDNAs was conducted in HCT116 cells. Results: Compared to NR patients, R patients exhibited enrichment of eccDNAs derived from chromosome 9, shorter median eccDNA lengths, and reduced variability in eccDNA length. All 4.9–5.0 kb eccDNAs derived from CKM , while other eccDNAs showed a strong genomic distribution correlation between groups (Spearman’s ρ = 0.73). Promoter-derived eccDNAs were enriched in R patients, particularly from the promoter of CARD9 (eccPromoter-CARD9, 10.4-fold increase). Overexpression of eccPromoter-CARD9 significantly promoted CRC cell proliferation and migration. R patients exhibited elevated eccDNAs harboring the hsa-mir-374c cluster in plasma and tissues, and their corresponding miRNAs demonstrated exceptional diagnostic accuracy in CRC-related TCGA cohorts. An eccDNA-based random forest classifier achieved superior recurrence prediction accuracy (AUC > 0.8), correlating with shorter time-to-recurrence (HR = 3.79) and elevated CA125 and CEA levels. Additional eccDNA-based models effectively predicted recurrence-associated mortality (AUC ≥ 0.93). Conclusions: The plasma eccDNA landscape may serve as an early and powerful non-invasive biomarker for CRC prognostication, optimizing risk stratification and guiding personalized treatment.
- Open Access
- 27 May 2024
- Published by Elsevier in Clinical Surgical Oncology
Comparation of single or staged surgical management in acute obstructive non-metastatic colorectal cancer patients aged over 75
- 27 May 2024
- Published by Elsevier in Clinical Surgical Oncology
Open AccessComparation of single or staged surgical management in acute obstructive non-metastatic colorectal cancer patients aged over 75
- Open Access
- 22 February 2024
- Published by Elsevier in Clinical Surgical Oncology
- Vol. 3 (1)
Impact of preoperative subcutaneous adipose, visceral adipose and skeletal muscle on the outcomes of the oldest-old colorectal cancer patients after surgery
- 22 February 2024
- Published by Elsevier in Clinical Surgical Oncology
- Vol. 3 (1)
Open AccessImpact of preoperative subcutaneous adipose, visceral adipose and skeletal muscle on the outcomes of the oldest-old colorectal cancer patients after surgery
- 7 October 2022
- Published by Wolters Kluwer Health in Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery
- Vol. 57 (10) , 1219-1224
[Application of lateral upper arm free flap in the repair of postoperative defects of oral cancer].
Objective: To explore the clinical application and efficacy of lateral upper arm free flap (LUAFF) for one-stage repairing of soft tissue defect after oral cancer surgery. Methods: This article was a retrospective analysis of clinical data of 46 patients receiving treatment of one-stage repairing of soft tissue defect with LUAFF after oral cancer surgery in Hunan Cancer Hospital, from June 2019 to June 2021. Among these cases, 40 were males, and 6 were females. The patients' ages were from 23 to 64 years old. The clinical data of patients were reviewed and outcomes were evaluated. SPSS 23.0 software was used for statistical analysis. Results: In the LUAFF of 46 patients, flap area ranged from 5.0 cm×3.5 cm to 15.0 cm×7.0 cm; the mean pedicle length was 8.15±1.42 cm; the mean artery diameter was 1.20±0.41 mm (range, 1.5 to 2.5 mm); the mean diameter of the largest veins was 2.15±0.52 mm; and the median number of perforators was 2.6 (range, 1 to 4). All donor sites were closed primarily. Two cases had arterial anastomosis thrombosis, but their flaps were successfully saved with urgent re-anastomosis of the vessels. The overall flap survival rate was 93.5%(43/46), with flap necroses after operation in three cases. No patient received tracheotomy. The average hospital stay time of patients after operation was 9.4 days. The follow-up time was 6-24 months, elbow and wrist movements on the operative side were normal, and the upper limb muscle strength was not affected. Conclusions: LUAFF is a suitable choice for the repairs of small-moderate tissue defects in oral cancer surgery, with consistent perforators in the flap, simple harvest method, concealed donor-site scar, and high survival rate.
- 7 October 2022
- Published by Wolters Kluwer Health in Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery
- Vol. 57 (10) , 1219-1224
[Application of lateral upper arm free flap in the repair of postoperative defects of oral cancer].
Objective: To explore the clinical application and efficacy of lateral upper arm free flap (LUAFF) for one-stage repairing of soft tissue defect after oral cancer surgery. Methods: This article was a retrospective analysis of clinical data of 46 patients receiving treatment of one-stage repairing of soft tissue defect with LUAFF after oral cancer surgery in Hunan Cancer Hospital, from June 2019 to June 2021. Among these cases, 40 were males, and 6 were females. The patients' ages were from 23 to 64 years old. The clinical data of patients were reviewed and outcomes were evaluated. SPSS 23.0 software was used for statistical analysis. Results: In the LUAFF of 46 patients, flap area ranged from 5.0 cm×3.5 cm to 15.0 cm×7.0 cm; the mean pedicle length was 8.15±1.42 cm; the mean artery diameter was 1.20±0.41 mm (range, 1.5 to 2.5 mm); the mean diameter of the largest veins was 2.15±0.52 mm; and the median number of perforators was 2.6 (range, 1 to 4). All donor sites were closed primarily. Two cases had arterial anastomosis thrombosis, but their flaps were successfully saved with urgent re-anastomosis of the vessels. The overall flap survival rate was 93.5%(43/46), with flap necroses after operation in three cases. No patient received tracheotomy. The average hospital stay time of patients after operation was 9.4 days. The follow-up time was 6-24 months, elbow and wrist movements on the operative side were normal, and the upper limb muscle strength was not affected. Conclusions: LUAFF is a suitable choice for the repairs of small-moderate tissue defects in oral cancer surgery, with consistent perforators in the flap, simple harvest method, concealed donor-site scar, and high survival rate.
- 6 July 2022
- Published by Wolters Kluwer Health in Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
- Vol. 56 (7) , 952-959
[The preference for Front-of-Pack Labeling and its association with the understanding of Nutrition Facts Panel among residents aged 18 to 70: results of a survey in 6 provinces of China].
Objective: To investigate the preference for Front-of-Pack Labeling (FOP) and its association with the understanding of the Nutrition Facts Panel among Chinese residents. Methods: A multi-stage sampling strategy was adopted to select 3 002 people aged between 18 and 70 years old from the eastern region of China (Beijing, Jiangsu Province, Guangdong Province), the northeast region (Heilongjiang Province), the central region (Henan Province) and the western region (Sichuan Province) from July 2020 to March 2021. Socio-demographic characteristics of participants and their understanding of the Nutrition Facts Panel and preference for FOP were collected. The χ² test was conducted to compare the preference for FOP in different groups of population, and multivariate logistic regression was used to analyze the association between the preference for FOP and the understanding of the Nutrition Facts Panel. Results: The mean age of 3 002 participants was (42.3±13.4) years, of which 1 914 (63.8%) were females and 69.3% could not understand the Nutrition Facts Panel. About 2 458 respondents (81.9%) suggested that FOP could be promoted. The top three nutrients that should be labeled were sugar (68.4%), salt (68.2%) and total fat (62.4%). The number of participants who believed that the Multiple Traffic Lights (MTL) could be easier to help consumers to quickly choose healthy food, attract attention and provide the most needed information was 1 064 (35.4%), 1 026 (34.2%) and 1 140 (38.0%), respectively. The multivariate logistic regression analysis showed that, compared with the Guideline Daily Amount (GDA) system, participants who could not understand the Nutrition Facts Panel preferred (1) Nutri-Score, Warning labels, and Health logos: Smart Choice in terms of"Which format of FOP could quickly help you choose food more easily?"[OR (95%CI): 2.21 (1.62-3.02), 1.64 (1.22-2.22), 1.79 (1.31-2.45), respectively]; (2) Nutri-Score, Warning labels, and Health logos: Smart Choice in terms of"Which format of FOP could attract your attention the most?"[OR (95%CI): 2.62 (1.92-3.59), 1.96 (1.45-2.66), 2.25 (1.66-3.04), respectively]; and (3) Nutri-Score, Warning labels, and Health logos: Smart Choice in terms of"Which format of FOP could provide you with the most needed information?"[OR (95%CI): 2.33 (1.70-3.21), 2.21 (1.66-2.95), 2.01 (1.50-2.71), respectively]. Conclusion: The residents from six provinces in China have a supportive attitude towards FOP. The interpretive FOP with color information, specific nutrient information and summary indicator can be launched. The nutrition information of sugar, salt and total fat could be prioritized to be labeled on the FOP.
- 6 July 2022
- Published by Wolters Kluwer Health in Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
- Vol. 56 (7) , 952-959
[The preference for Front-of-Pack Labeling and its association with the understanding of Nutrition Facts Panel among residents aged 18 to 70: results of a survey in 6 provinces of China].
Objective: To investigate the preference for Front-of-Pack Labeling (FOP) and its association with the understanding of the Nutrition Facts Panel among Chinese residents. Methods: A multi-stage sampling strategy was adopted to select 3 002 people aged between 18 and 70 years old from the eastern region of China (Beijing, Jiangsu Province, Guangdong Province), the northeast region (Heilongjiang Province), the central region (Henan Province) and the western region (Sichuan Province) from July 2020 to March 2021. Socio-demographic characteristics of participants and their understanding of the Nutrition Facts Panel and preference for FOP were collected. The χ² test was conducted to compare the preference for FOP in different groups of population, and multivariate logistic regression was used to analyze the association between the preference for FOP and the understanding of the Nutrition Facts Panel. Results: The mean age of 3 002 participants was (42.3±13.4) years, of which 1 914 (63.8%) were females and 69.3% could not understand the Nutrition Facts Panel. About 2 458 respondents (81.9%) suggested that FOP could be promoted. The top three nutrients that should be labeled were sugar (68.4%), salt (68.2%) and total fat (62.4%). The number of participants who believed that the Multiple Traffic Lights (MTL) could be easier to help consumers to quickly choose healthy food, attract attention and provide the most needed information was 1 064 (35.4%), 1 026 (34.2%) and 1 140 (38.0%), respectively. The multivariate logistic regression analysis showed that, compared with the Guideline Daily Amount (GDA) system, participants who could not understand the Nutrition Facts Panel preferred (1) Nutri-Score, Warning labels, and Health logos: Smart Choice in terms of"Which format of FOP could quickly help you choose food more easily?"[OR (95%CI): 2.21 (1.62-3.02), 1.64 (1.22-2.22), 1.79 (1.31-2.45), respectively]; (2) Nutri-Score, Warning labels, and Health logos: Smart Choice in terms of"Which format of FOP could attract your attention the most?"[OR (95%CI): 2.62 (1.92-3.59), 1.96 (1.45-2.66), 2.25 (1.66-3.04), respectively]; and (3) Nutri-Score, Warning labels, and Health logos: Smart Choice in terms of"Which format of FOP could provide you with the most needed information?"[OR (95%CI): 2.33 (1.70-3.21), 2.21 (1.66-2.95), 2.01 (1.50-2.71), respectively]. Conclusion: The residents from six provinces in China have a supportive attitude towards FOP. The interpretive FOP with color information, specific nutrient information and summary indicator can be launched. The nutrition information of sugar, salt and total fat could be prioritized to be labeled on the FOP.
- Open Access
- 16 February 2021
- Published by IOP Publishing in Environmental Research Letters
- Vol. 16 (3) , 035007
Association of short-term air pollution with systemic inflammatory biomarkers in routine blood test: a longitudinal study
The biological mechanisms behind health effects of air pollution have not been well known. Inflammation plays an important role in occurrence and development of a wide range of diseases. In this study, we assessed the effects of short-term exposure to ambient air pollution on systemic inflammatory biomarkers among 12 508 participants who underwent routine physical examination annually at the Hebei General Hospital in Shijiazhuang, China. For each participant, white blood cell count (WBC), lymphocytes, neutrophils and eosinophils were measured for two or three times during September 2016 to December 2018. Daily concentrations of nitrogen dioxide (NO2), sulfur dioxide (SO2), ozone (O3) and particulate matter less than 2.5 µm in aerodynamic diameter (PM2.5) were interpolated to each district, where the participants worked. The linear mixed-effects regression with a constrained distributed lag model was applied to examine the associations between air pollution and inflammatory biomarkers during lag 0–14 d. It was observed that WBC, neutrophils and eosinophils [percent change (%Δ) and 95% confidence interval (95%CI)] significantly decreased by −0.07 (−0.11, −0.04), −0.08 (−0.12, −0.03) and −0.15 (−0.25, −0.05) at lag 14 d, associated with per 10 µg m−3 increase in O3. WBC, lymphocytes and eosinophils (%Δ and 95%CI) significantly elevated by 0.08 (0.04, 0.12), 0.16 (0.11, 0.21) and 0.22 (0.10, 0.35) at lag 0 d, associated with per 10 µg m−3 increase in PM2.5. This study reveals short-term effects of air pollution on systemic inflammatory biomarkers in routine blood test, which is helpful for further study to explore the biological mechanisms.
- 16 February 2021
- Published by IOP Publishing in Environmental Research Letters
- Vol. 16 (3) , 035007
Open AccessAssociation of short-term air pollution with systemic inflammatory biomarkers in routine blood test: a longitudinal study
The biological mechanisms behind health effects of air pollution have not been well known. Inflammation plays an important role in occurrence and development of a wide range of diseases. In this study, we assessed the effects of short-term exposure to ambient air pollution on systemic inflammatory biomarkers among 12 508 participants who underwent routine physical examination annually at the Hebei General Hospital in Shijiazhuang, China. For each participant, white blood cell count (WBC), lymphocytes, neutrophils and eosinophils were measured for two or three times during September 2016 to December 2018. Daily concentrations of nitrogen dioxide (NO2), sulfur dioxide (SO2), ozone (O3) and particulate matter less than 2.5 µm in aerodynamic diameter (PM2.5) were interpolated to each district, where the participants worked. The linear mixed-effects regression with a constrained distributed lag model was applied to examine the associations between air pollution and inflammatory biomarkers during lag 0–14 d. It was observed that WBC, neutrophils and eosinophils [percent change (%Δ) and 95% confidence interval (95%CI)] significantly decreased by −0.07 (−0.11, −0.04), −0.08 (−0.12, −0.03) and −0.15 (−0.25, −0.05) at lag 14 d, associated with per 10 µg m−3 increase in O3. WBC, lymphocytes and eosinophils (%Δ and 95%CI) significantly elevated by 0.08 (0.04, 0.12), 0.16 (0.11, 0.21) and 0.22 (0.10, 0.35) at lag 0 d, associated with per 10 µg m−3 increase in PM2.5. This study reveals short-term effects of air pollution on systemic inflammatory biomarkers in routine blood test, which is helpful for further study to explore the biological mechanisms.
- 24 September 2019
- Published by Spandidos Publications in Oncology Reports
- Vol. 42 (6) , 2788-2796
Palmitoylome profiling indicates that androgens regulate the palmitoylation of α‑tubulin in prostate cancer‑derived LNCaP cells and supernatants
Prostate cancer is closely associated with constitutive transactivation of the androgen receptor (AR) signaling pathway. After treatment with androgen-deprivation therapy (ADT), the majority of patients develop castration-resistant prostate cancer within months or years. In order to investigate potential novel therapeutic targets in addition to ADT, the present study examined the regulatory mechanisms of the AR signaling pathway. In the present study, LNCaP cells were metabolically-labeled with Alk-C16, a palmitate probe. In addition, cells were treated with R1881, an androgen, or DMSO. Subsequently, click-chemistry-based palmitoylome profiling was performed in LNCaP cells and palmitoylated proteins were compared between cells treated with androgen and untreated cells. Androgen treatment was revealed to significantly increase the palmitoylation level of alpha-tubulin. In addition, the palmitoylation level of Ras-related protein Rab-7a (Rab7a) was enhanced by androgen treatment. Palmitoylation of alpha-tubulin and Rab7a were essential for cell proliferation. Notably, in the supernatant of LNCaP cells, the palmitoylation level of alpha-tubulin was also increased following androgen treatment. Palmitoylation of alpha-tubulin may provide a new potential target for the treatment of prostate cancer. In addition, the high level of alpha-tubulin palmitoylation in the supernatant may represent a biomarker for early-stage prostate cancer.
- 24 September 2019
- Published by Spandidos Publications in Oncology Reports
- Vol. 42 (6) , 2788-2796
Palmitoylome profiling indicates that androgens regulate the palmitoylation of α‑tubulin in prostate cancer‑derived LNCaP cells and supernatants
Prostate cancer is closely associated with constitutive transactivation of the androgen receptor (AR) signaling pathway. After treatment with androgen-deprivation therapy (ADT), the majority of patients develop castration-resistant prostate cancer within months or years. In order to investigate potential novel therapeutic targets in addition to ADT, the present study examined the regulatory mechanisms of the AR signaling pathway. In the present study, LNCaP cells were metabolically-labeled with Alk-C16, a palmitate probe. In addition, cells were treated with R1881, an androgen, or DMSO. Subsequently, click-chemistry-based palmitoylome profiling was performed in LNCaP cells and palmitoylated proteins were compared between cells treated with androgen and untreated cells. Androgen treatment was revealed to significantly increase the palmitoylation level of alpha-tubulin. In addition, the palmitoylation level of Ras-related protein Rab-7a (Rab7a) was enhanced by androgen treatment. Palmitoylation of alpha-tubulin and Rab7a were essential for cell proliferation. Notably, in the supernatant of LNCaP cells, the palmitoylation level of alpha-tubulin was also increased following androgen treatment. Palmitoylation of alpha-tubulin may provide a new potential target for the treatment of prostate cancer. In addition, the high level of alpha-tubulin palmitoylation in the supernatant may represent a biomarker for early-stage prostate cancer.
- Open Access
- 17 January 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (23) , 37845-37854
The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
- 17 January 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (23) , 37845-37854
Open AccessThe combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
- Open Access
- 1 March 2016
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 2 (1) , 10-16
Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy
Neoadjuvant therapy has become the standard of care for locally advanced mid‐low rectal cancer. Pathological complete response (pCR) can be achieved in 12%–38% of patients. Patients with pCR have the most favorable long‐term outcomes. Intensifying neoadjuvant therapy and extending the interval between termination of neoadjuvant treatment and surgery may increase the pCR rate. Growing evidence has raised the issue of whether local excision or observation rather than radical surgery is an alternative for patients who achieve a clinical complete response after neoadjuvant therapy. Herein, we highlight many of the advances and resultant controversies that are likely to dominate the research agenda for pCR of rectal cancer in the modern era.
- 1 March 2016
- Published by Wiley in Chronic Diseases and Translational Medicine
- Vol. 2 (1) , 10-16
Open AccessAdvances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy
Neoadjuvant therapy has become the standard of care for locally advanced mid‐low rectal cancer. Pathological complete response (pCR) can be achieved in 12%–38% of patients. Patients with pCR have the most favorable long‐term outcomes. Intensifying neoadjuvant therapy and extending the interval between termination of neoadjuvant treatment and surgery may increase the pCR rate. Growing evidence has raised the issue of whether local excision or observation rather than radical surgery is an alternative for patients who achieve a clinical complete response after neoadjuvant therapy. Herein, we highlight many of the advances and resultant controversies that are likely to dominate the research agenda for pCR of rectal cancer in the modern era.